首页> 外文期刊>Oncology letters >Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data
【24h】

Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data

机译:miR-122-5p在肝细胞癌中的潜在临床价值和推定生物学功能:使用微阵列和RNA测序数据进行综合研究

获取原文
获取原文并翻译 | 示例
           

摘要

In order to determine the diagnostic efficacy of microRNA (miR)-122-5p and to identify the potential molecular signaling pathways underlying the function of miR-122-5p in hepatocellular carcinoma (HCC), the expression profiles of data collected from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and literature databases were analyzed, along with any associations between clinicopathological characteristics and the diagnostic value of miR-122-5p in HCC. The intersection of 12 online prediction databases and differentially expressed genes from TCGA and GEO were utilized in order to select the prospective target genes of miR-122-5p in HCC. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein-protein interaction network (PPI) analyses were subsequently performed based on the selected target genes. The average expression level of miR-122-5p was decreased in HCC patients compared with controls from TCGA database (P0.001), and the downregulation of miR-122-5p was significantly associated with HCC tissues (P0.001), tumor vascular invasion (P0.001), metastasis (P=0.001), sex (P=0.006), virus infection status (P=0.001) and tissue (compared with serum; P0.001) in cases from the GEO database. The pooled sensitivity and specificity for miR-122-5p to diagnose HCC were 0.60 [95% confidence interval (CI), 0.48-0.71] and 0.81 (95% CI, 0.70-0.89), respectively. The area under the curve (AUC) value was 0.76 (95% CI, 0.72-0.80), while in Meta-DiSc 1.4, the AUC was 0.76 (Q*=0.70). The pooled sensitivity and specificity were 0.60 (95% CI, 0.57-0.62) and 0.79 (95% CI, 0.76-0.81), respectively. A total of 198 overlapping genes were selected as the potential target genes of miR-122-5p, and 7 genes were defined as the hub genes from the PPI network. Cell division cycle 6 (CDC6), minichromosome maintenance complex component 4 (MCM4) and MCM8, which serve pivotal functions in the occurrence and development of HCC, were the most significant hub genes. The regulation of cell proliferation for cellular adhesion and the biosynthesis of amino acids was highlighted in the GO and KEGG pathway analyses. The downregulation of miR-122-5p in HCC demonstrated diagnostic value, worthy of further attention. Therefore, miR-122-5p may function as a tumor suppressor by modulating genome replication.
机译:为了确定microRNA(miR)-122-5p的诊断疗效,并鉴定肝细胞癌(HCC)中miR-122-5p功能的潜在分子信令途径,从癌症基因组收集的数据表达谱分析了阿特拉斯(TCGA),基因表达综合征(地理学)和文献数据库,以及临床病理特征与HCC中miR-122-5p的诊断价值之间的任何关联。利用了12个在线预测数据库和来自TCGA和地理的差异表达基因的基因,以选择HCC中miR-122-5p的前瞻性靶基因。基因本体学(GO),基因和基因组(KEGG)和蛋白质 - 蛋白质相互作用网络(PPI)分析基于所选择的靶基因进行。与来自TCGA数据库(P <0.001)的对照相比,HCC患者中MIR-122-5P的平均表达水平降低,MIR-122-5P的下调与HCC组织(P <0.001)显着相关(P <0.001),肿瘤血管侵袭(P <0.001),转移(P = 0.001),性别(P = 0.006),病毒感染状态(P = 0.001)和组织(与血清相比; P <0.001),在来自GEO数据库的情况下。 miR-122-5p诊断HCC的汇集灵敏度和特异性分别为0.60 [95%置信区间(CI),0.48-0.71]和0.81(95%CI,0.70-0.89)。曲线(AUC)值下的区域为0.76(95%CI,0.72-0.80),而在元盘1.4中,AUC为0.76(Q * = 0.70)。合并的敏感性和特异性分别为0.60(95%CI,0.57-0.62)和0.79(95%CI,0.76-0.81)。选择总共198个重叠基因作为miR-122-5p的潜在靶基因,7个基因被定义为来自PPI网络的集线基因。细胞分裂循环6(CDC6),致枢轴功能在HCC的发生和发展中提供关键功能的细胞分裂循环组分4(MCM4)和MCM8是最重要的枢纽基因。在GO和KEGG途径分析中突出了对细胞粘附性和氨基酸生物合成的调节和氨基酸的生物合成。 MIR-122-5P在HCC中的下调证明了诊断价值,值得进一步关注。因此,MiR-122-5P可以通过调节基因组复制来用作肿瘤抑制剂。

著录项

  • 来源
    《Oncology letters》 |2018年第6期|共12页
  • 作者单位

    Guangxi Med Univ Dept Med Ultrason Affiliated Hosp 1 6 Shuangyong Rd Nanning 530021 Guangxi;

    Guangxi Med Univ Dept Pathol Affiliated Hosp 1 Nanning 530021 Guangxi Zhuang Peoples R China;

    Guangxi Med Univ Dept Pathol Affiliated Hosp 1 Nanning 530021 Guangxi Zhuang Peoples R China;

    Guangxi Med Univ Dept Pathol Affiliated Hosp 1 Nanning 530021 Guangxi Zhuang Peoples R China;

    Guangxi Med Univ Dept Pathol Affiliated Hosp 1 Nanning 530021 Guangxi Zhuang Peoples R China;

    Guangxi Med Univ Dept Pathol Affiliated Hosp 1 Nanning 530021 Guangxi Zhuang Peoples R China;

    Guangxi Med Univ Dept Med Ultrason Affiliated Hosp 1 6 Shuangyong Rd Nanning 530021 Guangxi;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    microRNA-122-5p; hepatocellular carcinoma; diagnosis; bioinformatics analysis;

    机译:microRNA-122-5P;肝细胞癌;诊断;生物信息学分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号